Boehlen D, Borner M, Sonntag RW, Fey MF, studer UE: Long-termresults following adjuvant chemotherapy in patients with clinicalstage I testicular nonseminomatous malignant germ cell tumor
Danh mục Tài liệu tham khảo Tiếng Việt 10 11 12 13 14 15 16 17 Phạm Hoàng Anh (11/1995), "Ung th ngời Hà Nội", Tạp chí Y học thực hành, tr.90-98 phạm Hoàng Anh, Chu Hoàng Hạnh, Nguyễn Bá Đức, Trịnh Đức Vách (2000), "Nhận xét hoạt động chẩn đoán điều trị ung th số bệnh viện tỉnh khu vực đồng bắc bộ", Tạp chí thông tin Y dợc chuyên đề ung th, Bộ Y TÕ- ViƯn Th«ng tin th viƯn y häc Trung ơng, tr.12-15 Nguyễn Thị Ân (2000), Nghiên cứu đặc điểm lâm sàng hiệu Human Chorionic Gonadotropin (HCG) điều trị tinh hoàn không xuống bìu trẻ em, Luận văn tốt nghiệp thạc sĩ Đặng Thế Căn, Đoàn Hữu Nghị, Trịnh Văn Quang ( ), Ung th tinh hoàn bệnh viên K( 1956-1980) Kỷ yếu công trình NCKH ung th Trơng Cam Cống, Phạm Văn Địch, Nguyễn Văn Ngọc, Đỗ Kính (2000), Mô học phôi thai học đại cơng, Nxb Y học, Hà Nội Đỗ Trung Đàm (1995), Thuốc chữa ung th, Nxb Y học, Hà Nội Nguyễn Bá Đức (2000), Hoá chất điều trị bệnh ung th, Nxb Y học, Hà Nội Nguyễn Bá Đức (2003), Thực hành xạ trị bệnh ung th, Nxb Y học, Hà Nội Nguyễn Bá Đức (2006), Phòng phát sớm bệnh ung th, Nxb Hà Nội Nguyễn Văn Hiếu (11/1999), Chẩn đoán bệnh ung th- Bài giảng tập huấn điều trị tia xạ ung th, Bệnh viện K xuất Trần Đức Hoè (2003), "Phẫu thuật ung th tinh hoàn'', Những kỹ thuật ngoại khoa tiết niệu, Nxb Khoa học kỹ thuật, Hà Nội Đỗ Xuân Hợp (1997), Giải phẫu bụng, Nxb Y học, Hà Nội Trần Quốc Hùng (2000), Đặc điểm lâm sàng, cận lâm sàng ung th tinh hoàn đánh giá phơng pháp điều trị phối hợp số thể bệnh thờng gặp (1988-2000), Luận văn thạc sĩ Y học Nguyễn Chấn Hùng ( ), Ung th học lâm sàng, tËp 2, Nxb Y häc, Thµnh Hå ChÝ Minh Ngô Gia Hy (1997), Ung th tinh hoàn, Niệu học tËp 1, Nxb Y häc, Hµ Néi Nelson W E (1982), Các quan sinh dục, Khái luận nhi khoa (sách dịch), Nxb Y học, Hà Nội Đoàn Hữu Nghị, Phạm Hoàng Anh (1991), "Phân bố ung th theo ti", T¹p chÝ Y häc ViƯt Nam, tËp 158, tr.20-25 18 Đoàn Hữu Nghị (2001), Ung th học lâm sàng, ung th tinh hoµn, Nxb Y häc, Hµ Néi 19 Nguyễn Thu Nhạn (1997), Tật tinh hoàn ẩn Cẩm nang điều trị nhi khoa, Nxb Y học, Hà Nội 20 Nguyễn Xuân Phách (11/1999), Những vấn đề sinh học phóng xạ- giảng tập huấn điều trị tia xạ ung th, Bệnh viện K xuất bản, Hà Nội 21 Nguyễn Quang Quyền (2000), Tinh hoàn Lạc chỗ, Bách khoa th bệnh học, Nxb Y học, Hà Néi 22 Ngun Bưu TriỊu (1999), BƯnh häc tiÕt niƯu- Ung th tinh hoµn, Nxb Y häc, Hµ Néi 23 Lê Ngọc Từ (2000), Bệnh học tiết niệu Tinh hoàn lạc chỗ, Nxb Y học, Hà Nội 24 Võ Văn Xuân (1996), Tình hình chẩn đoán điêù trị ung th tinh hoµn ë bƯnh viƯn K Hµ Néi (1979-1993), Luận văn tốt nghiệp thạc sĩ 25 Võ Văn Xuân ( ), "Nhận xét chẩn đoán điều trị ung th tinh hoàn Bệnh viện K Hà Nội (1979-1988)", Tạp chí Tổng hội y dợc học Việt Nam, tËp 173, tr 113-117 TiÕng Anh 26 Abratt RP, Pontin AR, Barnes RD, Reddi BV: adjuvant chemotherapy for stage I non-seminomatous testicular cancer S Afr Med J 1994;84:605-607 27 Alan Horwich (2000), Testicular cancer, Invertigation and manegement William& Wilkins Baltimor, Hongkong, London, Munich, Philadenphia, Sydney, Tokyo 28 Albers P, Albrecht W, Algaba F, et al Guidelines on testicular cancer European Urology.2005;48:885-894 29 AlomaryI, Samant R, Gallant V (2006), Treatment of stage seminoma: 15 year review Urol Oncol 2006;24: 180-183 30 American Cancer Society Cancer facts and Fugures Alanta (1999), Autor 31 American joint Committee on Cancer Testis In: AJCC Cancer Staging Manual 6th ed New York: Springer; 2002:317-322 32 Aprikian AG, Herr HW, Bajorin DF, Bosl GJ: Resection of postchemotherapy residual masses and limited retroperitoneal 33 34 35 36 37 38 39 40 41 42 43 lymphadenectom in patients with metastatic testicular nonseminomatous germ cell Cancer 1998;74:1329-1334 Arai Y, Kawakita M, Hida S, Terachi T, Okada Y, Yoshida O: Psychosocial aspects in long-term survivors of testicular cancer J Urol 1996;155:574-578 Austoker J: Screening for ovarian, prostatic, and testicular cancers BMJ 1994;309:315-320 Bamberg M, Schmidberger H, Meisner C, Classen J, Souchon R, Weinknecht S, Schorcht J, Walter F, Engenhart-Cabillic R, Schulz U, Born H, Flink M: Radiotherapy for stages I and II A/B testicular seminoma Int J Cancer 1999;83:823-827 Banienl J,foster RS, Donohue JP, Einhorn LH: Late relapse of clinical stage I testicular cancer.J Urol 1995;154:1370-1372 Banienl J,foster RS, Rowland RG, Bihrle R, Donohue JP: Complications of primary retroperitoneal lymph -node dissection for low-stage testicular cancer World J Urol 1999;12:139-142 Baniel J, Roth BJ, Foster RS, Donohue JP: Cost-and - Risk- Benefit consideration in the management of Clinical Stage NSGCT Ann Surg Oncol 1996;3:86-93 Bajorin DF, Geller NL, Weisen SF, Bosl GJ: Two -drug therapy in patients with metastatic germ cell tumors Cancer 1991;67:28-32 Bergstrom R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, Tretli S, TeppoL, Akre O, Hakulinen T: Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon J Natl cancer Inst 1996; 88:727-733 Boehlen D, Borner M, Sonntag RW, Fey MF, studer UE: Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors J Urol 1999;161: 1148-1152 Boehlen D, Borner M, Sonntag RW, et al: Long term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ-cell tumors with high-risk factors J Urol 161:1148-1152,1999 Bosl, Motzer RJ: Testicular germ cell cancer N Engl Med 337: 242253,1997 44 Bosl GJ, Bajorin DF, Sheinfeld J et al Cancer of the testis In: DeVita VT, HellmanS, Rosenberg SA, eds Cancer : Principles and Practice of Oncology Philadelphia, Pa: Lippincott William& Wilkins; 2005:1269-1294 45 Buetow SA: Testicular cancer : To screen or not to screen ? J Med Screen 1996; 3:3-6 46 Chris B Bringhurst, MD Robert Amato, Do Division of Medicine, The University of Texas M.D Anderson Cancer Centre, Houston, Texas: Testicular Cancer Medical Oncology: A Comprehensive review;1997:1-35 47 Colls BM, Harvey VJ, Skelton L,et al Late results of surveilance of clinical stage I nonseminoma germ cell testicular tumors 17 years experience in a national study in New Zealand BJU Int 1993 83:76-82 48 Csapo Z, Bornhof C, Giedl J: Impalpable testicular tumors diagnosed by scrotal ultrasonography Urology 1988;32:549-552 49 Culine S, Theodore C, Terrier- Lacombe MJ, Droz JP (1996), Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis and biological disease only after orchiectomy J.Urol;155:1296-1298 50 Cullen MH, Stenning SP, Parkinson MC, Fossa SD, Kaye SB, Horwich AH, Harland SJ, Williams MV, Jakes R: Short -course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Reseach Council report J Clin Oncol 1996; 14:1106-1113 51 Daugaard G, Giwercman A, Skakebaek NE: Should the other testis be biopsied? Semin Urol Oncol 1996;14:8-12 52 David per, Robert Sawin (2000), Teratomas and Other Germ cell tumors- Surgical pediatrics, Mosby, page 447-454 53 Davis SD: CT evaluation for pulmonary metastases in patients with extrathoracic malignancy Radiology 1991;180:1-12 54 Dixon FJ, Moor RA (1952), Tumors of the male sex organ, in Atlas of Tumor Pathology, fascicle 31b-32, Washington, DC, Armed Forces institute of Pathology 55 Dieckmann KP, Loy V: The value of the biosy of the contralateral testis in patients with testicular germ cell cancer: the recent German experience APMIS 1998; 106:13-20 56 Dieckmann KP, Bruggeboes B, Pichimeier U, Kuster J, Mullerleile U, Barteis H: Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient? Urology 2000;55:102-106 57 Dooms GC, Hricak H, Moseley ME, Bottles K, Fisher M, Higgins CB: Characterization of lyphadenopathy by magnetic resonance relaxation times : preliminary results Radiology 1985;155:691-697 58 Doherty AP, Bower M, christmas TJ: The role of tumor markers in the diagnosis and treatment of testicular germ cell cancer Br J Urol 1997;79:247-252 59 Doherty AP, Bower M, Christmas TJ: The role of tumour markers in the diagnosis and treatment of testicular germ cell cancer Br J Urol 79:247-252,1997 60 Donohue JP, Thornhill JA, Foster RS, Bihrle R, Rowland RG, Einhorn LH: The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer : the Indiana University experience (1965 to1989) J Urol 1995;153:85-89 61 Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R: Clinical stage B non-seminomatous germ cell testis cancer : the Indiana University experience (1965-1989) using routine primary retroperitoneal lymph node dissection Eur J Cancer 1995;31A:1599-1604 62 Donohue JP, foster RS, Rowland RG, Bihrle R, JonesJ, Geier G: Nervesparing retroperitoneal lyphadenectomy with preservation of ejaculation J Urol 2000;144:287-291 63 Donohue JP (2003), Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT) Urologic Oncology: Seminars and Original Investigations ;21:129-132 64 Einhor LH: Salvage therapy for germ cell tumors Semin Oncol 21(suppl7) : 47-51, 1994 65 Facob Rajfer M.D (1999), Congenital Anpmalies of the Testis Campbells urology :1543-1547 66 Fernandez EB, Colon E, McLeaod DG, Moul JW: Efficasy of radiographic chest imaging in patients with testicular cancer Urology 1994;44:243-248 67 68 69 70 71 72 73 74 75 76 Fossa SD, Chen J, Schonfeld SJ, et al Risk of contralateral testicular cancer: a population based study of 299,515 US men J Ntl Cancer Inst 2005;97:1056-1066 Foster RS, Roth BJ: Clinical stage I nonseminoma: surgery versus surveillance Semin Oncol 1998;25:145-153 Foster R, Bihrle R (2002), Current status of retroperitoneal lymph node dissection and testicular cancer When to operate, Cancer Control;9:277-283 Fossa SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ, Jones WG, Yosef H, Duchesne GM, Owen JR, Grosch EJ, Chetiyawardana AD, Reed NS, Widmer B, Stenning SP: Optimal planning target volume for stage I testicular seminoma: A Medical Reseach Council randomized trial Medical Reseach Council Testicular Tumor Working Group J Clin Oncol 1999;17:1146 Fossa SD, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE: Is postchemotherapy retoperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? J Clin Oncol 1999; 10:569-573 Freedman, L.S., Parkinson, M.C., Jones, W.G et al Histopathology in the prediction of patients with stage I testicular teratoma treated by orchidectomy alone Lancet, ii, 294-8 1987 L.Garreta, J Bassoulet: Cancer National Cancer Institute- Testicular Cancer Reseach Report Public health Service: NIH Publication 1987-16p Geurts van Kessel A, Seiykerbwjk RF, Sinke RJ, et al: Molecular cytogenetics of human germ cell turmors: i (12p) and related chromosomal anomalies 3rd Copenhagen Workshop: Carcinoma in-situ and Cancer of the Testis, p2 November 1-4, 1992, Copenhagen, Denmark, 1992 Gerl A, Lamerz R, Clemm C, Mann K, Wilmanns W: Does serum tumor marker half - life complement pretreatment risk stratification in metastatic nonseminomatours germ cell tumors? Clin Cancer Res 2: 1565-1570,1996 Gibert JB , Hamiltol JB (1940), Studies in malignant testis tumor: III Incidence and nature of tumors in ectopic testes, Surg Gynecol Obstet 71:731-743 Gospodarowicz M, Sturgeon JF, Jewitt MA Early stage and advanced seminoma: role of diation therapy, surgery, and chemotherapy Semin Oncol 1998;25:160-173 78 Gospodarowicz M, SturgeronJF, JewittMA (1998), Early stage and advanced seminoma: role of radiation therapy, surgery, and chemotherapy Semin Oncol; 25: 160-173 79 Hansen PV, Trykker H, Svennekjaer IL, Hvolby J: Long -term recovery of spermatogenesis after radiotherapy in patients with testicular 77 80 81 82 83 84 85 86 87 88 cancer Radiother Oncol 1990 Heidenreich, A, Sesterhenn, IA, Moul, JW: Prognosis risk factor in low stage testicular germ cel tumors: Unanswered questions regarding clinical userful prognosticators for extratesticular disease (editorial- counterpoint) Cancer 79:1641-1645,1997 Heidenreich, A, Sesterhenn IA, Mostofi FK, et al: Prognosis risk factor that identify patients with clinical stage I nonseminomatous germcell tumors at low risk for metastases Cancer 83:1002-1011, 1998 P Hermanek R.V.P Huntter L.H.Sobin G Wagner Ch.Wittekind(Eds)UICC (2004), TNM Atlas- springer; 280-294 Herr HW, Sheinfeld J: is biopsy of the contralateral testis necessary in patients with germ cell tumor ? J Urol 1997; 158:1331-1334 Herr HW: Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer ? Br J Urol 1997;80:653-657 R Honda Stewart M.D – Barbara A Carroll M.D (1997), The Scrotum Chapter 26 Campbell’s urologys urology, page 565-567 Horwich A, Huddart R, Dearnaley D: Markers and management of germ -cell tumours of the testes Lancet 1998;352:1535-1538 Horwich A, Norman A, FisherC, Hendry WF, Nicholls J, Dearnaley DP: Primary chemotherapy for stage II nonseminomatous germ cell tumors of the testis J Urol 1999;151:72-77 Hogeboom WR, Hoekstra HJ, Mooyaart EL, Sleijfer DT, Freling NJ, Willemse PH, Schraffordt KH: The role of magnetic resonance imaging and computed tomography in the treatment evaluation of retroperitoneal lymph-node metastases of non-seminomatous testicular tumors Eur J Radiol 1991;13:31-36 89 Horwich A, Shipley J, Huddart R Testicular germ -cell cancer Lancet 2006;17:218-237 90 IARC (2006), Cancer in five Continents, Volume V, page 412-517 91 International Germ Cell Consensus Classification: a prognostic factorbased staging system for metastatic germ cell cancer , International Germ cell cancer Collaborative Group [see comment] J Clin Oncol 1997;15:594-603 92 Janetschhek G, Hobisch A, Peschel R,et al Laparoscopic retroperitoneal lymph node dissection Urology 2000;55:136-140 93 Jewett MA: Nerve-sparing technique for retroperitoneal lymphadenectomy in testis cancer Urol Clin North Am 1990; 17:449-456 94 John M (1998), HUtson- Undescended Testis, Torsion, and VaricoceleMosby 1087-1089 95 Jones WG, Fosa SD, Mead GM, at al Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and treatment of Cancer Trial 30942 (ISRCTN 18525328) J Clin Onco l 2005; 23:1200-1208 96 Jones RH, Vasey PA Part (2003), Testicular Cancer- management of early disease The Lancet Oncology, 4: 730-737 97 Klepp O, Olsson AM, Henrikson H, Aass N, Dahl O, Stenwig AE, Persson BE, Cavallin - Stahi E, Fossa SD, Wahlqvist L: Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis : multivariate analysis of a prospective multicenter study Swedish - Norwegian Testicular Cancer Group J Clin Oncol 1990;8:509-518 98 Kondagunta GV, Bacik J, Bajorin D, et al (2005), Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors JClin Oncol; 23:9290-9294 99 Koshida K, Nishino A, Yamamoto H, et al: The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors J Urol 146:57-60, 1991 100 Lamerz R: Alpha-fetoprotein In L Thomas(ed) Clinical laboratory Diagnostics, 1st ed., TH-Books Verlagsgesellschaft, Frankfurt am Main 1998, pp 941-945 101 Lange PH, Fraley EE (1997), Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors Urol Clin North Am 4: 393-406 102 Lawrence H Einhorn E David Crawford William U Shipley Patrick J Loehrer Sterphen D Williams Cancer of the testes chapter 35 campbell s urology1999: 1071-1097 103 Lawren H Einher-Jerome P Rich- William U Shiple (1997), Chapter Cancer of the testis & Principles Practice of Oncology-4 Edication by Vincent Devita J.B Lippin scotte Company- Philadelphia 104 Ledermann JA, Holden ES, Newlands RHJ: the long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumors Br J Urol 74: 225- 230, 1994 105 Leibovtch I, Foster RS, Kopecky KK, Albers P, Ulbright TM, Donohue JP: Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment J Clin Oncol 1998;16:261-268 106 Lenz S, Skakkebaek NE, Hertel NT: Abnormal ultrasonic pattern in contralateral testes inpatients with unilateral testicular cancer World J Urol 1996; 14 Suppl 1:S55-S58 107 Llouis R, Kavoussi,MD, The Johns Hopkins, Oncology Centre, Baltimore, Maryland Laparoscopic vs Open Retroperitoneal Lyphadenectomy Oncology , Vol 13, No 12; 12-1999:10-17 108 Levy P, Menzelxhiu A, Paillot B, Bretagne JF, Flejou JF, Bernades P: Abdominal radiotherapy is a cause for chornic pancreatitis Gastroenterology 1993;105:905-909 109 Loehrer PJ, Sr., Johnson D, ElsonP, Einhorn LH, TrumpD: Importance of bleomycin in favorable - prognosis disseminated germ cell tumors : an Eastern Cooperative Oncology Group trial J Clin Oncol 1995;13:470-476 110 Lwanga SK and Lemeshow S: Sample size determination in health studies, A Practical Manual, World Health Organization Generva.1998 111 Mckiernan JM, Goluboff ET, Liberson GL, Golden R, FischH: Rising risk of testicular cancer by birth cohort in the United States from 1973-1999; 162:361-363 112 Meinardi MT, Gietema JA, van der Graaf WTA, et al Cardiovascular morbidity in long -term survivors of metastatic testicular cacer Jclin Oncol 2000;18:1725-1732 113 Moller, Skakkebaek NE: Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark Cancer causes Cotrol 1997 ;8:904-912 114 Moller H, Skakkebaek NE: Risk of Testicular cancer in subfertile men: case-control study BMJ 1999; 318:559-562 115 Motzer RJ, Gulati SC, Crown J, et al: High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors : Early intervention is better tolerated Cancer 69:550556,1992 116 Mostofi FK (1973), Testiscular tumors: Epidemiologic, etiologic and pathologic features, Cancer 32: 1186-1201 117 National Academy of Clinical Biochemistry: Standards of laboratory practice Guidelines for the analytical performance and clinical utility of tumor markers Germ cell tumors Workshop of the joint national meeting of the CLAS and NACB, May 1998, Rye Brook, N.Y 118 National Cancer Institute Clinical Trial Results: Chemo for Early- Stage Testicular Cancer More Effecctive than Lymph- Node Dissection in Preventing Relapse American Society of Clinical Oncology (ASCO) , annual meeting, Atlanta (see the meeting abstract);June 4,2006:1-3 119 NCCN (2007), Testicular Cancer TOC Staging, MS, References Practice Guidelines in Oncology- v.i 120 Nicolai N, Pizzocaro G: A surveilance study of clinical stage I nonseminomatous germ cell tumors of the testis : 10 -year followup J Urol 1995;154:1045-1049 121 Nichols-CR: Division of Hematology/ Oncology, Oregon Helth Sciences University, Portland, USA Curr-Probl-Cancer 1998 Jul-Aug; 22(4): 187-247 122 Nichols CR, Catalano PJ, Crawford ED, Vogeizang NJ, Einhorn LH, Loehrer PJ: Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced Group, and Cancer and Leukemia Group B Study[see comments] J Clin Oncol 1998;16:1287-1293 123 Nichols CR, Williams SD, Loehrer PJ, Greco FA, Crawford ED, Weetlaufer J, Miller ME, Bartolucci A, Schacter L, Einhorn LH: Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.J.Clin Oncol 1999;9:1163-1172 124 Oliver, R.T.D., Nouri, A.M.E., Crosby, D et al Biological significance of beta HCG, HLA other membrane antigen expression on bladder tumour and their relationships to tumour infiltrating lymphocytes j Immuno- genetics.1990 125 Oliver RT, Edmonds PM, Ong JY, Ostrowski MJ, Jackson AW, Baille Johnson H, Williams MV, Wiltshire CR, Mott T, Partt WR: Pilot studies of and course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 1994;29:3-8 126 Patel SR, K vols LK, Richardson RL (1990), Familial testicular cancer: Report of six cases and review of the literature Mayo Clin Proc 65: 804-808 127 Pierik FH, Dohle GR, van Muiswinkel JM, Vreeburg JT Weber RF: is routine scrotal ultrasound advantageous in infertile men? J Urol 1999;162: 1618-1620 128 Polak V, Hornak M: The value of scrotal ultrasound in patients with suspected testicular tumor Int Urol Nephrol 1990;22:467-473 129 Pont J Albrecht W, Postner G, Sellner F, Angel K, Holti W: Adjuvant chemotherapy for high-rish clinical stage I nonseminomatous testicular germ cell cancer : long -term results of a prospective trial J Clin Oncol 1996;14:441-448 130 Rabbani F, Goldenberg SL, Gleave ME, Paterson RF, Murray N, Sullivan LD: Retroperitoneal lymphadenectomy for post-chemotherapy residual masses : is a modified dissection and resection of residual masses sufficient? Br J Urol 1998;81:295-300 131 Rabbani F, Sheinfeld J, Farivar Mohseni H, et al Low volume nodal metastases detected at retroperitoneal lyphadenectomy for testicular cancer : pattern and prognosis factors for replapse J Clin Oncol 2001;7:2020-2025 132 Radiological Society of North America, Inc: Ultrasound Imaging of the Scrotum.2007;1-5 133 Raghavan D,ed American Cancer Society Atlas of Clinical OncologyTesticular Cancer Hamilton, London: BC Decker;2003 134 Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB, CookPA: Medical Research Coucil prospective study of surveillance for stage I testicular teratoma Medical Research Coucil Testicular Tumors Working Party J Clin Oncol 1992 ; 10:1762-1768 135 Retichie JP Detection and treatment of testicular cancer CA Cancer J Clin 1999; 43:151-175 136 Richard J Andrassy Cynthia Corpron, Michael Ritchey (1998), Testiscular tumors Surgical pediatrics, Mosby, page 541-545 137 Richard S Foster, MD Indiana University Medical Center, Indianapolis, Indiana CraiR Nichols, MD Oregon Health Sciences University, Portland, Oregon Testicular Cancer: What s New in Staging, Prognosis, and Therapy Oncology vol 13, No12; 12-1999:1-17 138 Richard Foster, MD, and Richard Bihrle, MD: Current Status of Retroperitoneal Lymph Node Dissection and Testicular Cancer: When to Operate Deparment of Urology at Indiana University School of Medicine Indianapolis Indiana Vol 9, No ;82002:277-283 139 Richie JP: Clinical stage testicular cancer :the role of modified retroperitoneal lymphadenectomy J Urol 1990;144:1160-1163 140 Richie JP Detection and treatment of testicular cancer CA Cancer J Clin 1993;43:151-75 141 Sabroe-S; Olsen-J: Department of Epidemiology Jensen OM, Olsen JH, Osterlind A Testis cancer and Social Medicine, University of Aarhus, Denmark Int-J-Cancer 1998 Oct 5; 78(2): 140-3 142 Sakai N, Yamada , Asao T, Murayama T: Sonographically-detected impalpable testicular cancer with retroperitoneal bulky metastases: a case report Int J Urol 1997;4:533-534 143 Saller B.et al Testicular cancer secretes intact human choriogonadotropin (HCG) and its free - submit : evidence that HCG (+ HCG- ) assays are the most reliable in diagnosis and follow-up Clin Chem.36,234-239, 1990 144 Schottenfeld D, Warshauer ME, Sherlock, et al (1980), The epidemiology of testicular cancer in young adults Am J Epidemiol 112: 232-246 145 See WA, Hoxie L: Chest staging in testis cancer patients: imaging modality selection based upon risk assessment as determined by abdominal computerized tomography scan results J Urol 1993;150:874-878 146 Sesterhenn IA, Weiss RB, Mostofi FK, Stablein DM, Rowland RG, Falkson G, Rivkind SE, Vogelzang NJ: Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Group J clin Oncol 1992;10:69-78 147 Srinivas S, Terris M: Management choices in stage I NSGCT Pro Am Soc Clin Oncol (abstract) 18:328a,1999 148 Steele GS, Richie JP Current role of retroperitoneal lymph node dissection in testicular cancer Oncology (Huntingt) 1997;11:717-729 149 Steyerberg EW, Donohue JP, Gerl A, Toner GC, Schraffordt KH, Fossa SD, Keizer HJ: Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retoperitoneal and pulmonary histology Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group J Urol 1997;158:474-478 150 Steyerberg EW, Keizer HJ, Habbema JD: Prediction models for the histology of residual masses after chemotherapy for metastatic testicular cancer ReHiT Study Group J Urol 1999;83:856-859 151 Strader CH, Weiss NS, Daling JR, et al (1988), Cryptorchism, orchiopexy, and the risk of testicular cancer Am J Epidemiol 127: 1013-1318 152 Strader CH, Weiss NS, Daling JR, Karagas MR, McKnigh B Cryptorchidism, orchiopexy, and the risks of testicular cancer Am J Epidemiol 2001;127: 1013-8 153 I.Struve, Abbott GmbH (2004), Tumour markers, Tumour Diseases- A Clinical Guide, Dabur oncology: 42-62 154 Sturgeron JF, Jewett MA, AlisonRE, Gospodaroowicz MK, Blend R, Herman S, Richmond H, Thomas G, Duncan W, MunroA: Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors J Clin Oncol 1992;10:564-568 155 Sumner WA (1958), Malignant tumor of the testis occurring 29 years after orchiopexy: Case report and review of literature Trans West sect Am Urol Assoc 25:20-24 156 SwerdlowAJ, Higgins CD, Pike MC: Risk of Testicular cancer in cohort of boys with cryptorchidism in BMJ 1997 Nov 1;315(7116):1129 157 Toner GC, Stockler MR, Boyer MJ, et al (2001), Comparison of two standard chemotherapy regiments for good-prognosis germ-cell tumors: a randomized trial Australian and New Zealand Germ Cell Trial Group Lancet ; 357:739-745 158 Tumour markers in germ cell cancer: EGTM recommendations European Group on Tumour Markers Anticancer Res 1999; 19:2795-2798 159 Vergouwe Y, Steyeberg EW, Foster RS, et al Validation of a prediction model and it s predictors for the histology of residual masses in nonseminnomatous testicular cancer J Urol 2001;165:84-88 160 Warde P, Gospodarowicz MK, Panzarella T, Catton CN, Sturgeon JF, Moore M, Goodman P, Jewett MA: Stage testicular seminoma : results of adjuvant irradiation and surveillance J Clin Oncol 1995;13:2255-2262 161 Warde P, Gospodarowicz MK, Banerjee D, Panzarella T, Surgar L, Catton CN, Sturgeon JF, Moore M, Jewett MA: Prognostic factors for relapse in stage I testicular seminoma treated with surveillance J Urol 1997;157:1705-1709 162 Westergaard T, Olsen JH, Frisch M, Kroman N, Nielsen JW, Melbye M: Cancer risk in fathers and brothers of testicular cancer patients in Denmark A population -based study Int J Cancer 1996;66:627631 163 P.R Wheater, HG Bur Kitt, V G Paniels Llustratred by P.J Deakin Foreword by R WarWick- Male Reproductive organ, Functional Histology, A text and Colour Atlas 1993 467-490 164 White PM, Howard GC, Best JJ, Wright AR: The role of computed tomographic examination of the pelvis in the management of testicular germ cell tumours Clin Radiol 1997;52:124-129 165 Wingo PA, Tong T, Bolden S (1991), Cancer Statistics, 1995 CA Cancer J Clin 41:19-36 166 Yeoh E, Horowitz M, Russo A, Muecke T, RobbT, Maddox A, Chatterton B: Effect of pelvic irradiation on gastrointestinal function: a prospective longitudinal study Am J Med 1993;95:397-406 167 Young BJ, Bultz BD, Russell JA, Trew MS: Compliance with follow-up of patients treated for non-seminomatous testicular cancer Br J Cancer 1999;64:606-608 TiÕng Ph¸p: 168 Aubergert JT; Berlizoe P: Annales D urologie, 1997,26(2):76-78 169 C.Debonniere, J Veyssiere: le cancer du testicule Guide Pratique Telecobaltherapie 23 Rue D ecole de Medicine Paris 6-1980,57-63 170 L.Garreta, J Bassoulet: Cancer du Testicule Strategie therapeutique en Cancerologie Paris 1986, 181-189 171 Schill H; Arborio.M; Gros.P; Grippari: Anatomie Pathologique des Tumeurs Du Testicule.Ann-Urol,1992,26(2):83-89 172 Scheye.T; Larroquet.M: Tritto.G; Brue'ziere.J L'ectopie Testiculaire Notions Actuelles.Ann Urol,1992,26(4):212-217